M

Mersin University | Mersin University Hospital - Department of Gastroenterology

Research site
(Unclaimed)
Location
Mersin University, Mersin, Mersin, Turkey
Site insights

Top conditions

Anxiety Disorders (2 trials)

Procedural Pain (2 trials)

Fatigue (2 trials)

Dysmenorrhea (2 trials)

Breast Cancer (2 trials)

Top treatments

Mirikizumab
Anastrozole
LY3502970
Exemestane
Imlunestrant
Tamoxifen
Lenalidomide
Abemaciclib
LY3561774
Letrozole

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

10 of 42
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Locations recently updated
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Enrolling
Crohn's Disease
Drug: Mirikizumab

The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabete...

Enrolling
Chronic Kidney Disease
Overweight
Drug: Orforglipron
Drug: Insulin Glargine

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cance...

Enrolling
Breast Neoplasms
Drug: Letrozole
Drug: Tamoxifen
Locations recently updated

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy, and how well imlunestrant with abemaci...

Enrolling
Neoplasm Metastasis
Breast Neoplasms
Drug: Exemestane
Drug: Imlunestrant
Locations recently updated

The main purpose of this study is to assess the efficacy and safety of LY3540378 in adults with worsening heart failure with preserved ejection fract...

Enrolling
Heart Failure With Preserved Ejection Fraction
Heart Failure
Drug: LY3540378
Drug: Placebo
Locations recently updated

This a multicenter, Phase 2b, double-blind, placebo-controlled, parallel group study to provide data on efficacy and safety of LY3561774 administered...

Active, not recruiting
Metabolic Diseases
Lipid Metabolism Disorders
Drug: Placebo
Drug: LY3561774

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab (R^2) in participants with r...

Enrolling
Relapsed/Refractory Follicular Lymphoma
Marginal Zone Lymphoma
Drug: Rituximab
Drug: Zanubrutinib
Locations recently updated

This study is designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative col...

Enrolling
Ulcerative Colitis
Drug: Mirikizumab
Locations recently updated

A Phase 3, randomized, blinded study comparing pelabresib (CPI-0610) and ruxolitinib with placebo and ruxolitinib in myelofibrosis (MF) patients that...

Active, not recruiting
Myelofibrosis
Post-essential Thrombocythemia Myelofibrosis
Drug: Pelabresib
Drug: Placebo

Trial sponsors

M

Mersin University (27 trials)

Lilly logo

Lilly (8 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems